2025. In Silico Study of Secondary Metabolite in Asiatic Pennywort (Centella asiatica) as a Drug Compound for Blood Cancer  (Acute Lymphoblastic Leukemia (ALL)) Targeting JAK-2 Receptor. Indonesian Journal of Chemical Science. 14, 1 (May 2025), 18–27. DOI:https://doi.org/10.15294/ijcs.v14i1.8946.